<SEC-DOCUMENT>0001641172-25-013158.txt : 20250530
<SEC-HEADER>0001641172-25-013158.hdr.sgml : 20250530
<ACCEPTANCE-DATETIME>20250530215603
ACCESSION NUMBER:		0001641172-25-013158
CONFORMED SUBMISSION TYPE:	3/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250429
FILED AS OF DATE:		20250530
DATE AS OF CHANGE:		20250530

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Ho Jien Shiung
		CENTRAL INDEX KEY:			0002068628
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50626
		FILM NUMBER:		251012941

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		15, JALAN EKOFLORA 5/1
		STREET 2:		TAMAN EKOFLORA
		CITY:			JOHOR BAHRU
		NON US STATE TERRITORY:  	JOHOR
		PROVINCE COUNTRY:   	N8
		ZIP:			81100

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cyclacel Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001130166
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				911766850
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922
		BUSINESS PHONE:		908-517-7330

	MAIL ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XCYTE THERAPIES INC
		DATE OF NAME CHANGE:	20001218
</SEC-HEADER>
<DOCUMENT>
<TYPE>3/A
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3/A</documentType>

    <periodOfReport>2025-04-29</periodOfReport>

    <dateOfOriginalSubmission>2025-05-15</dateOfOriginalSubmission>

    <noSecuritiesOwned>1</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001130166</issuerCik>
        <issuerName>Cyclacel Pharmaceuticals, Inc.</issuerName>
        <issuerTradingSymbol>CYCC</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0002068628</rptOwnerCik>
            <rptOwnerName>Ho Jien Shiung</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>LEVEL 10, TOWER 11,</rptOwnerStreet1>
            <rptOwnerStreet2>AVENUE 5, NO. 8, JALAN KERINCHI</rptOwnerStreet2>
            <rptOwnerCity>KUALA LUMPUR,</rptOwnerCity>
            <rptOwnerState>N8</rptOwnerState>
            <rptOwnerZipCode>59200</rptOwnerZipCode>
            <rptOwnerStateDescription>MALAYSIA</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>1</isOther>
            <officerTitle></officerTitle>
            <otherText>Shareholder</otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <remarks>This Form 3 amendment is being filed to correct the original Form 3 filed on May 15, 2025 which was filed in error as the Reporting Person is not an officer, director or ten percent owner of the outstanding shares of common stock of Cyclacel Pharmaceuticals, Inc. and therefore not obligated to file a Form 3. The Reporting Person is not voluntarily subjecting itself to Section 16 reporting.</remarks>

    <ownerSignature>
        <signatureName>/s/ Ho Jien Shiung</signatureName>
        <signatureDate>2025-05-30</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
